---
schema_version: "secwatch.filing_event.v1"
accession: "0001428336-23-000020"
form_type: "8-K"
ticker: "HQY"
cik: "0001428336"
company_name: "HEALTHEQUITY, INC."
filed_at: "2023-06-05T23:59:59+00:00"
generated_at: "2026-06-14T07:16:25.270809+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# HealthEquity Q1 revenue $244.4M (+19%), net income $4.1M vs loss, raises FY guidance

## Summary
- Revenue $244.4M (+19% YoY); GAAP EPS $0.05; non-GAAP EPS $0.50 vs $0.27.
- Adjusted EBITDA $86.6M (+48%), margin 35% vs 28%.
- HSA accounts 8.0M (+9%); total HSA assets $22.3B (+10%).
- FY2024 guidance raised: revenue $975-985M, Adj. EBITDA $333-343M, non-GAAP EPS $1.88-$1.97.
- Early repaid $50M variable-rate debt; cites strong profitability.

## SEC filing metadata
- accession: 0001428336-23-000020
- form_type: 8-K
- ticker: HQY
- cik: 0001428336
- company_name: HEALTHEQUITY, INC.
- filed_at: 2023-06-05T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1428336/000142833623000020/0001428336-23-000020-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1428336/000142833623000020/hqy-20230605.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001428336-23-000020
- JSON: https://secwatch.observer/filing/0001428336-23-000020.json
- Plain text: https://secwatch.observer/filing/0001428336-23-000020.txt

## Key facts
- Earnings Releases
  HEALTHEQUITY, INC. reported fiscal year ending January 31, 2024 results: revenue $975 million to $985 million, net income $9 million and $14 million, EPS $0.10 to $0.16 per diluted share. Guidance raised.
  - Period: fiscal year ending January 31, 2024
  - Revenue: $975 million to $985 million
  - Net income: $9 million and $14 million
  - EPS: $0.10 to $0.16 per diluted share
  - Guidance: raised
  - Result: guidance update
  source text: For the fiscal year ending January 31, 2024, management expects revenue of $975 million to $985 million. Its outlook for net income is between $9 million and $14 million, resulting in net income of $0.10 to $0.16 per diluted share.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1428336/000142833623000020/0001428336-23-000020-index.htm
- Earnings Releases
  HEALTHEQUITY, INC. reported results: revenue $244.4 million, net income $4.1 million, EPS $0.05 per diluted share. Guidance raised.
  - Revenue: $244.4 million
  - Net income: $4.1 million
  - EPS: $0.05 per diluted share
  - Guidance: raised
  - Result: reported results
  source text: in such a filing. --- EX-99.1 (EX-99.1) --- HealthEquity Reports First Quarter Ended April 30, 2023 Financial Results Highlights of the first quarter include: • Revenue of $244.4 million, an increase of 19% compared to $205.7 million in Q1 FY23. • Net income of $4.1 million, compared to net loss of $13.6 million in Q1 FY23, with non-GAAP net income of $42.8
  evidence_url: https://www.sec.gov/Archives/edgar/data/1428336/000142833623000020/0001428336-23-000020-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.